Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlović S.
Burch PA, et al. Among authors: richardson rl.
Clin Cancer Res. 2000 Jun;6(6):2175-82.
Clin Cancer Res. 2000.
PMID: 10873066
Clinical Trial.